Reference Links
The following information is provided for background information only. TherapeuticsMD is not responsible for any content provided by third-party sites.
HORMONE THERAPY POSITION PAPERS AND CONSENSUS STATEMENTS
The 2013 British Menopause Society & Women's Health Concern Recommendations on Hormone Replacement Therapyhttp://min.sagepub.com/content/19/2/59.full.pdf+html
Global Consensus Statement on Menopausal Hormone Therapy
https://www.endocrine.org/news-room/press-release-archives/2013/global-consensus-statement-on-menopausal-hormone-therapy
The 2012 Hormone Therapy Position Statement of The North American Menopause Society
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3443956/
HORMONE THERAPY OVERVIEW
A Decade After the Women’s Health Initiative – The Experts Do Agreehttps://www.fertstert.org/article/S0015-0282(12)00605-X/fulltext
HORMONE THERAPY CLINICAL TRIAL ARTICLES
Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort studyhttp://www.ncbi.nlm.nih.gov/pmc/articles/PMC2211383/
Effects of Estrogen or Estrogen/Progestin Regimens on Heart Disease Risk Factors in Postmenopausal Women The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial
http://jama.jamanetwork.com/article.aspx?articleid=386103
VULVOVAGINAL ATROPHY (VVA)
Postmenopausal Vaginal Atrophy Therapeutics - Pipeline Assessment and Market Forecasts to 2019https://www.asdreports.com/shopexd.asp?id=27833&desc=Postmenopausal+Vaginal+Atrophy+Therapeutics+-+Pipeline+Assessment+and+Market+Forecasts+to+2019
Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause Society
https://www.menopause.org/docs/default-source/2013/vva-position-statement.pdf?sfvrsn=0
Urogenital aging—A hidden problem
http://www.sciencedirect.com/science/article/pii/S0002937898705551
The Day-to-Day Impact of Urogenital Aging: Perspectives from Racially/Ethnically Diverse Women
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2811605
Urogenital aging: The diagnosis and management of vaginal atrophy
http://www.parkhurstexchange.com/clinical-reviews/mar12/urogenital-aging
BIOIDENTICAL HORMONES
Bioidentical hormones: what is all the hype about?http://informahealthcare.com/doi/abs/10.3109/13697130903550250
Compounded Bioidentical Menopausal Hormone Therapy – Committee Opinion ACOG and ASRM
http://www.acog.org/~/media/Committee%20Opinions/Committee%20on%20Gynecologic%20Practice/co532.pdf?dmc=1&ts=20130729T1637409150
Misconception and Concerns about Bioidentical Hormones Used for Custom-Compounded Hormone Therapy
http://jcem.endojournals.org/content/97/3/756.full.pdf
Bioidentical compounded hormones: A pharmacokinetic evaluation in a randomized clinical trial
http://www.maturitas.org/article/S0378-5122(13)00019-4/abstract
LINKS
North American Menopause Societyhttp://www.menopause.org
The North American Menopause Society (NAMS) is North America's leading nonprofit organization dedicated to promoting the health and quality of life of all women during midlife and beyond through an understanding of menopause and healthy aging.
American Society of Reproductive Medicine
http://www.asrm.org
ASRM is a multidisciplinary organization dedicated to the advancement of the art, science, and practice of reproductive medicine. The Society accomplishes its mission through the pursuit of excellence in education and research and through advocacy on behalf of patients, physicians, and affiliated health care providers.
NIH ClinicalTrials.gov
http://www.ClinicalTrials.gov
The NIH maintains a database of ongoing clinical trials where people can find information about specific clinical trials in their area. People who are interested should talk with their doctor and visit http://www.clinicaltrials.gov to learn more about clinical trials that may be appropriate.
*The following information is provided for background information only. TherapeuticsMD is not responsible for any content provided by third-party sites.
** Sponsored by TherapeuticsMD